BRIEF published on 08/14/2025 at 07:05, 8 months 24 days ago Relief Therapeutics Releases 2025 Half-Year Report Relief Therapeutics RLF-TD011 RLF-OD032 2025 Half-Year Report NeuroX Partnership
BRIEF published on 08/14/2025 at 07:05, 8 months 24 days ago Relief Therapeutics publie son rapport semestriel 2025 THÉRAPEUTIQUE DE SECOURS RLF-TD011 RLF-OD032 Rapport Semestriel 2025 Partenariat NeuroX
BRIEF published on 08/14/2025 at 07:05, 8 months 24 days ago Wacker Neuson Group Reports H1/2025 and Confirms 2025 Guidance Revenue Half-year Report EBIT Margin Wacker Neuson Group 2025 Guidance
BRIEF published on 08/14/2025 at 07:05, 8 months 24 days ago Le groupe Wacker Neuson publie ses résultats du premier semestre 2025 et confirme ses prévisions pour 2025 Marge EBIT Rapport Semestriel Revenu Orientations 2025 Groupe Wacker Neuson
BRIEF published on 08/14/2025 at 07:05, 8 months 24 days ago Brockhaus Technologies AG Reports Modest H1 2025 Revenue Growth Brockhaus Technologies Bikeleasing 2025 Outlook H1 2025 Revenue IHSE Margin
BRIEF published on 08/14/2025 at 07:05, 8 months 24 days ago Brockhaus Technologies AG annonce une croissance modeste de son chiffre d'affaires au premier semestre 2025 Brockhaus Technologies Location De Vélos Perspectives 2025 Chiffre D'affaires Du Premier Semestre 2025 Marge IHSE
BRIEF published on 08/14/2025 at 07:05, 8 months 24 days ago Le rilzabrutinib de Sanofi obtient la désignation de médicament orphelin dans l’UE Sanofi EMA Médicament Orphelin Rilzabrutinib Maladie IgG4
BRIEF published on 08/14/2025 at 07:05, 8 months 24 days ago Sanofi's rilzabrutinib granted orphan drug designation in the EU Sanofi EMA Orphan Drug Rilzabrutinib IgG4 Disease
BRIEF published on 08/14/2025 at 07:04, 8 months 24 days ago Grenke AG: First Half-Year 2025 Financial Update Half-year Report GRENKE AG Cost-income Ratio Franchise Acquisition 2025 Financial Results
BRIEF published on 08/14/2025 at 07:04, 8 months 24 days ago Grenke AG : Bilan financier du premier semestre 2025 GRENKE AG Rapport Semestriel Résultats Financiers 2025 Rapport Coûts-revenus Acquisition De Franchise
Published on 05/08/2026 at 01:50, 4 hours 45 minutes ago Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 5 hours 50 minutes ago Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 6 hours 35 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 7 hours 5 minutes ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 7 hours 20 minutes ago BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/07/2026 at 23:23, 7 hours 12 minutes ago H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 7 hours 21 minutes ago EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 8 hours 30 minutes ago Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 9 hours 53 minutes ago RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 11 hours 49 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 19:15, 11 hours 20 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 11 hours 20 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 11 hours 29 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 11 hours 29 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 11 hours 35 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
